Phase I–II feasibility trial of the addition of cisplatinum to epirubicin-vinorelbine combination (PEV) in metastatic breast cancer (MBC)
| Autor: | Turpin, F., Spielmann, M., Mobayen, H., Toussaint, C., Biville, F., Berthaud, P. |
|---|---|
| Zdroj: | In European Journal of Cancer 1993 29 Supplement 6:S84-S84 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|